Envista Holdings Corporation Common Stock (NY:NVST)

23.46 +0.30 (+1.30%)

Official Closing Price Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Envista Holdings Corporation Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Envista (NVST) To Report Earnings Tomorrow: Here Is What To Expect

February 03, 2026

Dental products company Envista Holdings (NYSE:NVST) will be reporting results this Thursday after market close. Here’s what investors should know.

Via StockStory

Topics Artificial Intelligence

1 Stock Under $50 to Keep an Eye On and 2 That Underwhelm

January 29, 2026

Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and...

Via StockStory

Chart Industries Exit Comes With a $210 Takeout Clock and $6 Billion Backlog ↗

January 29, 2026

Chart Industries supplies cryogenic and heat transfer equipment to energy, industrial gas, and specialty markets worldwide.

Via The Motley Fool

Topics Regulatory Compliance Supply Chain

Knife River Stock Has Tumbled 31% This Past Year, but One Fund Placed a $22 Million Bet on a Turnaround ↗

January 29, 2026

Knife River delivers construction materials and services for large U.S. infrastructure projects, serving both public and private clients.

Via The Motley Fool

Earnings Preview: Envista Holdings ↗

October 29, 2025

Via Benzinga

Solventum (SOLV): The 3M Spin-Off That Found Its Rhythm – A 2026 Deep-Dive Analysis

January 14, 2026

Date: January 14, 2026 Introduction Since its high-profile separation from industrial conglomerate 3M Company (NYSE: MMM) in April 2024, Solventum Corporation (NYSE: SOLV) has undergone a profound...

Via Finterra

Topics Artificial Intelligence World Trade

Dental Equipment & Technology Q3 Earnings: Envista (NYSE:NVST) Simply the Best

December 30, 2025

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Envista (NYSE:NVST) and its peers.

Via StockStory

Dental Equipment & Technology Stocks Q3 Results: Benchmarking Dentsply Sirona (NASDAQ:XRAY)

December 24, 2025

As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the dental equipment & technology industry, including Dentsply Sirona (NASDAQ:XRAY) and its peers.

Via StockStory

1 Momentum Stock with Impressive Fundamentals and 2 We Brush Off

December 17, 2025

The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant...

Via StockStory

1 Stock Under $50 with Exciting Potential and 2 We Brush Off

December 11, 2025

Via StockStory

Envista (NVST) Stock Trades Up, Here Is Why

December 09, 2025

Shares of dental products company Envista Holdings (NYSE:NVST) jumped 3.2% in the morning session after Barclays initiated coverage on the stock with an 'Overweight' rating and a $24 price target. The...

Via StockStory

Topics Artificial Intelligence Economy Supply Chain

1 Profitable Stock to Target This Week and 2 We Find Risky

November 23, 2025

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.

Via StockStory

Reflecting On Dental Equipment & Technology Stocks’ Q3 Earnings: Align Technology (NASDAQ:ALGN)

November 23, 2025

As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the dental equipment & technology industry, including Align Technology (NASDAQ:ALGN) and its peers.

Via StockStory

Envista, Alignment Healthcare, LifeStance Health Group, Avantor, and Bio-Techne Shares Are Soaring, What You Need To Know

November 21, 2025

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated...

Via StockStory

Topics Earnings Economy

Why One Investor Is Betting $30 Million on Western Union Despite 16% Stock Slide ↗

November 11, 2025

Why One Investor Is Betting $30 Million on Western Union Despite 16% Stock Slide

Via The Motley Fool

Topics Earnings Regulatory Compliance

5 Insightful Analyst Questions From Envista’s Q3 Earnings Call

November 06, 2025

Envista’s third quarter results exceeded Wall Street’s expectations, with management attributing performance to broad-based growth across its core businesses and a significant margin expansion. CEO...

Via StockStory

Topics Earnings

3 Reasons to Avoid NVST and 1 Stock to Buy Instead

November 04, 2025

Envista has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 18.7% to $20.15 per share while the index has gained 19.8%.

Via StockStory

Topics Government Stocks

What Does the Market Think About Envista Holdings Corp? ↗

November 03, 2025

Via Benzinga

NVST Q3 Deep Dive: Product Launches and Operational Gains Drive Margin Expansion

October 31, 2025

Dental products company Envista Holdings (NYSE:NVST) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 11.5% year on year to $669.9 million. Its non-GAAP profit of...

Via StockStory

Topics World Trade

Envista (NYSE:NVST) Surprises With Strong Q3

October 30, 2025

Via StockStory

Envista (NVST) Reports Earnings Tomorrow: What To Expect

October 28, 2025

Dental products company Envista Holdings (NYSE:NVST) will be reporting results this Thursday after market hours. Here’s what investors should know.

Via StockStory

Paradice Dumped Its Entire $15.2 Million Progressive Software Stake ↗

October 26, 2025

Paradice Dumped Its Entire $15.2 Million Progressive Software Stake

Via The Motley Fool

What's Driving the Market Sentiment Around Envista Holdings Corp? ↗

October 17, 2025

Via Benzinga

1 Stock Under $50 on Our Watchlist and 2 Facing Challenges

October 13, 2025

Via StockStory

Align Technology, Envista, Centene, Amphastar Pharmaceuticals, and Oscar Health Shares Plummet, What You Need To Know

October 10, 2025

A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump.

Via StockStory

Topics Economy Government World Trade

3 Small-Cap Stocks That Fall Short

October 06, 2025

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a...

Via StockStory

Topics Retirement

Align Technology, ResMed, Insulet, Envista, and Dentsply Sirona Shares Plummet, What You Need To Know

September 25, 2025

A number of stocks fell in the afternoon session after the U.S. Commerce Department initiated a national security investigation into medical equipment and devices, raising concerns about potential...

Via StockStory

Topics World Trade

Kerr Announces the Launch of SimpliCore(TM) Gutta Percha Carrier Obturators for Simplified Endodontics

September 15, 2025

Via ACCESS Newswire

Envista Holdings Corp (NYSE:NVST) Shows Strong Technical Setup and Breakout Potential ↗

September 10, 2025

Envista Holdings (NVST) shows strong technical momentum with a high-quality consolidation pattern, signaling a potential breakout opportunity for trend-focused traders.

Via Chartmill

2 Volatile Stocks on Our Watchlist and 1 That Underwhelm

September 08, 2025

Market swings can be tough to stomach, and volatile stocks often experience exaggerated moves in both directions. While many thrive during risk-on environments, many also struggle to maintain investor...

Via StockStory

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.